Clinical Trial Update: A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) [Phase 3]

View source ↗

Summary

Phase 3 study of MK0217A with a dietary supplement in men and postmenopausal women with osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Vitamin Deficiency

Drugs mentioned

• MK0217A

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoporosis, Vitamin D Deficiency | Phase 3 | Status: COMPLETED